نمایش پرونده ساده آیتم

dc.contributor.advisorAlivand, Mohammad Reza
dc.contributor.authorSabaei, Leila
dc.date.accessioned2021-01-31T08:29:24Z
dc.date.available2021-01-31T08:29:24Z
dc.date.issued2020en_US
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/63475
dc.description.abstractThe aim of the present study was to evulate the effect of doctaxel on the expression level of angiogenic factors on endothelial cells Methods: In this study, HUVEC cell line of gastric adenocarcinoma cells were cultured in RPMI1640 medium, then determined by MTTassay of effective dose and after 24 hours treatment with and Docetaxel changes of gene expression. The study was compared to the control group by Real Time PCR method. To evaluate the expression of the studied genes(mir106b,mir-21,mir-155 and HIF-1@). Results: Treatment of cells with DOC induced changes in expression of the studied genes. Based on the results of the study,the expression of metastasis-dependent genes was significantly increased in the treated cells compared to the untreated cells. The expression of MicroRNAs also significantly decreased in DOC-treated cells. In other words, DOC resulted in altered expression of genes involved in metastasis and angiogenesis.en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, Faculty of Medicineen_US
dc.relation.isversionofhttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/63474
dc.subjectmir106ben_US
dc.subjectmir-21en_US
dc.subjectmir-155en_US
dc.subjectHIF-1en_US
dc.titleStudy of the anti-angiogenic response of endothelial cells to the treatment with Docetaxel anti-cancer agenten_US
dc.typeThesisen_US
dc.contributor.supervisorShirmohammadi, Masoud
dc.contributor.supervisorKazemi, Tohid
dc.identifier.docno609744en_US
dc.identifier.callno9744en_US
dc.description.disciplineMedicineen_US
dc.description.degreeMD Degreeen_US


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم